Srisupundit S, Tangtrakul S, Linasmita V, Bullangpoti S, Kraiphibul P, Pojchanugool L
Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Gan To Kagaku Ryoho. 1995 Aug;22 Suppl 3:256-61.
This is a prospective non-randomized study of 127 patients with stage IIB carcinoma of the cervix treated with irradiation and followed by surgery at Ramathibodi Hospital between 1980 and 1989. The criteria for combined treatment were an enlarged cervical mass of over 5 cm, including a barrel-shaped cervix, inadequate or improper radium insertion due to obliterated cervical os, and endometrial extension. The 5-year survival rate was 84.37%. The incidence of pelvic failure was 10.2% and extrapelvic failure was 6.3%. Those revealing residual disease in hysterectomy specimens had a worse prognosis. The increase in the survival rate in this study as compared to other reports may have been due to the use of higher dosages of irradiation. It is concluded that combined treatment was effective in dealing with poor prognosis groups of carcinoma of the cervix. It improved the pelvic and extrapelvic control as well as the survival rate with acceptable complications.
这是一项前瞻性非随机研究,研究对象为1980年至1989年间在拉玛蒂博迪医院接受放疗并随后接受手术治疗的127例IIB期宫颈癌患者。联合治疗的标准为宫颈肿块增大超过5厘米,包括桶状宫颈、因宫颈口闭塞导致镭插入不足或不当以及子宫内膜受累。5年生存率为84.37%。盆腔失败发生率为10.2%,盆腔外失败发生率为6.3%。子宫切除标本中显示有残留病灶的患者预后较差。与其他报告相比,本研究中生存率的提高可能归因于使用了更高剂量的放疗。结论是,联合治疗对于处理宫颈癌预后较差的患者群体有效。它改善了盆腔和盆腔外控制以及生存率,且并发症可接受。